文献速递免疫规划

疫苗与急性播散性脑脊髓炎风险

Vaccines and the risk of acute disseminated encephalomyelitis.
PubMed 文献 · Vaccine · 2018-05-18

该嵌套病例对照研究纳入272例急性播散性脑脊髓炎病例和1096例对照,未观察到乙肝、流感、脊灰(减毒活)、白喉、百日咳(无细胞)、破伤风、麻疹、腮腺炎、风疹、日本脑炎、脑膜炎、甲肝、水痘和狂犬病疫苗接种增加急性播散性脑脊髓炎风险。31-60天暴露间隔内疫苗与风险统计学显著增加相关(OR 4.04,95%CI 1.07-12.69),但0-30天和61-180天间隔无此关联;疫苗与急性播散性脑脊髓炎复发无关联。

要点

  • 未观察到乙肝、流感、脊灰(减毒活)等疫苗接种增加急性播散性脑脊髓炎风险。
  • 31-60天暴露间隔内疫苗与风险增加相关(OR 4.04,95%CI 1.07-12.69)。
  • 疫苗与急性播散性脑脊髓炎复发无关联。

核心结论

  • 本研究结果未显示疫苗接种与儿童(≤18岁)或成人(>18岁)在接种后180天内急性播散性脑脊髓炎风险增加及其复发相关。
  • 儿童31-60天风险间隔内的发现很可能是巧合,且未在单独的自身对照分析中得到证实。

研究设计与样本

  • 2011年1月至2015年12月开展的嵌套病例对照研究,每例病例匹配4例对照,匹配因素为年龄、性别和地址。
  • 由独立专家委员会验证病例和对照的诊断,疫苗接种数据来自计算机化疫苗接种记录,采用条件logistic回归分析。

主要发现

  • 分析纳入272例急性播散性脑脊髓炎病例和1096例对照。
  • 未观察到乙肝、流感、脊灰(减毒活)、白喉、百日咳(无细胞)、破伤风、麻疹、腮腺炎、风疹、日本脑炎、脑膜炎、甲肝、水痘和狂犬病疫苗接种增加急性播散性脑脊髓炎风险。
  • 31-60天暴露间隔内疫苗与风险统计学显著增加相关(OR 4.04,95%CI 1.07-12.69),但0-30天和61-180天间隔无此关联。
  • 疫苗与急性播散性脑脊髓炎复发之间无关联。

关键数值与推荐

  • 31-60天暴露间隔内疫苗与急性播散性脑脊髓炎风险增加相关(OR 4.04,95%CI 1.07-12.69)。
  • 0-30天和61-180天暴露间隔内疫苗与急性播散性脑脊髓炎风险无统计学显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 儿童31-60天风险间隔内的发现很可能是巧合,且未在单独的自身对照分析中得到证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is important to examine the risk of Acute disseminated encephalomyelitis (ADEM) after vaccination. METHODS: We conducted a nested case-control study between January 2011 and December 2015. Four controls per case were matched for age, gender, address. An independent expert committee validated the diagnoses of cases and controls. Data on vaccinations were obtained from computerized vaccination records. The analyses were conducted with the use of conditional logistic regression. RESULTS: The analyses include 272 cases of ADEM and 1096 controls. No increase in the risk of ADEM was observed for vaccination against hepatitis B, influenza, polio(live), diphtheria, pertuss(acellular), tetanusis, measles, mumps, rubella, Japanese Encephalitis, meningitis, hepatitis A, varicella and rabies vaccines. Vaccine was associated with a statistically significant increase in risk in the 31-60-day exposure interval (OR, 4.04 [95% CI, 1.07-12.69]), but not the 0-30 and 61-180-day interval. There was no association between vaccine received and the recurrence of ADEM. CONCLUSIONS: Findings from the present study do not demonstrate an association of vaccines with an increased risk of ADEM and its recurrence among either paediatric (≤18 years) or adult (>18 years) individuals within the 180 days after vaccinations. The finding in children in the 31-60 day risk interval is likely coincidental and was not confirmed in separate self-control analyses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chen Y, Ma F, Xu Y, et al. Vaccines and the risk of acute disseminated encephalomyelitis. Vaccine. 2018. PMID: 29784468. doi:10.1016/j.vaccine.2018.05.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。